Tag Archives: Tumor-Associated Macrophages

Engineered extracellular vesicles precisely reprogram tumor-associated macrophages, boosting anti-tumor immunity and phagocytosis while suppressing tumor growth and metastasis in preclinical models...

A new biotinylation-based method enhances the loading of therapeutic peptides into extracellular vesicles, improving targeted delivery and boosting cancer immunotherapy effects in preclinical models...

RNA profiling shows that extracellular vesicles from HNSCC patients reprogram macrophages to suppress immune responses and promote metastasis...

Muller Fabbri, MD, PhD, of the Children’s Center for Cancer and Blood Diseases at Children’s Hospital Los Angeles, has been awarded $1.9 million by the National Cancer Institute of the NIH to further his research on neuroblastoma – the third most common ...